It is estimated that approximately 132,000 new cases of large bowel cancer are diagnosed annually in the US. Nearly 49,700 Americans die each year and it is the third most common cause of cancer death in the US. One in five patients with colorectal cancer presents with metastatic disease. The increasing of screening through colonoscopy has led to more cases being diagnosed at an asymptomatic stage. However, symptoms can include rectal bleeding, abdominal pain, unexplained iron deficiency anemia, and/or a change in bowel habits. Tests such as a fecal occult blood test or endoscopy are performed. Once the diagnosis is established, the disease is staged by physical exam and CT of the chest, abdomen, and pelvis. A carcinoembryonic antigen is drawn.
Treatment options can include surgery, adjuvant chemotherapy, chemotherapy and radiation in rectal cancers, and chemotherapy alone in metastatic disease. Chemotherapy gents used include 5-FU, leucovorin, oxaliplatin, irinotecan, cetuximab, panitumumab, and regorafenib.
Colorectal Cancer Specialists
Dr. Raymond Tsao completed his fellowship in Hematology & Medical Oncology at The Cleveland Clinic in Ohio. He is board certified in Medical Oncology, Hematology, and Internal Medicine. Dr. Tsao is currently seeing patients with all types of cancer, with a focus on Gastrointestinal Malignancies (including esophageal, stomach, colorectal, and pancreatic cancer). Click here to learn more about Dr. Raymond Tsao.
Dina Giovanetti received her BSN in 1994 and her MSN in 2002 from Florida Atlantic University. She is Board Certified as a Family Nurse Practitioner and has practiced in Internal Medicine and Emergency Medicine for most of her career before joining Cancer Center of South Florida and practicing Oncology. Click here to learn more about Dina Giovanetti.